Pharmaceuticals India

India Veterinary Drugs Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

India Veterinary Drugs Market Industry Trends and Forecast to 2034: Segmented by (Product, Animal, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

India · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $738.3 Mn Placeholder estimate
Estimate 2025 $812.2 Mn 1.9% of the global market
Projected 2034 $1.92 Bn 135.8% Adds $1.10 Bn over 9 forecast years
CAGR 2025–2034 10.0% Faster than 38% of 183 Pharmaceuticals markets here
Key players 6 +1
  • India is 1.87% of the global market.
  • In APAC, the largest is China at $4.04 Bn.
  • Fastest growing: India (this report) at 10% a year.
  • India ranks 4th of 14 by size in APAC.

Market size projection

India

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$1.10 Bn total, 2026–2034

Year-by-year market size, 2024–2034
Veterinary Drugs Market market size by year, India
YearMarket sizeChange that yearSince 2025
2024 (estimate) $738.3 Mn — —
2025 (base) $812.2 Mn +$73.8 Mn —
2026 (forecast) $893.4 Mn +$81.2 Mn +10%
2027 (forecast) $982.7 Mn +$89.3 Mn +21%
2028 (forecast) $1.08 Bn +$98.3 Mn +33.1%
2029 (forecast) $1.19 Bn +$108.1 Mn +46.4%
2030 (forecast) $1.31 Bn +$118.9 Mn +61.1%
2031 (forecast) $1.44 Bn +$130.8 Mn +77.2%
2032 (forecast) $1.58 Bn +$143.9 Mn +94.9%
2033 (forecast) $1.74 Bn +$158.3 Mn +114.4%
2034 (forecast) $1.92 Bn +$174.1 Mn +135.8%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

India Veterinary Drugs Market Analysis at a glance
Market size, 2025$812.2 Mn placeholder estimate
Forecast, 2034$1.92 Bn placeholder estimate
Growth (CAGR), 2025–203410.0% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct and animal (see all)
Key playersZoetis, Inc, Elanco, Merck & Co., Inc., Boehringer Ingelheim GmbH, Ceva Sante Animale and 1 more (see all)
Regulator in IndiaCDSCOSource: Central Drugs Standard Control Organisation. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The India Veterinary Drugs Market Analysis Executive Summary

Veterinary drugs are the medicines given to pets and farm animals to treat or prevent disease and pain.

Key segments of the veterinary drugs market include product (Anti-Infectives, Anti-Parasitics and Anti-Inflammatories) and animal (Dogs, Cats and Cattle).

Bar chart: India Veterinary Drugs market size, 2024–2034, placeholder estimates. $738.3 Mn in 2024, $812.2 Mn in 2025 and $1.92 Bn in 2034, 10.0% CAGR.
India Veterinary Drugs market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

India Veterinary Drugs Market Dynamics

Market Growth Drivers

More pet ownership, spending on pet care, rising demand for meat and milk, and concern about animal disease are driving the veterinary drugs market.

Opportunity

Long-acting treatments, tests that find disease early and growing pet spending in emerging countries give the veterinary drugs market room to grow.

Market Restraints

Rules on antibiotic use in farm animals, high drug prices for pet owners and shortages of vets in rural areas hold back the veterinary drugs market.

Competitive Landscape for Veterinary Drugs Market in India

The veterinary drugs market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Veterinary Drugs Market in India

Veterinary Drugs in India: rules and payment

New drugs and clinical trials need approval from the Central Drugs Standard Control Organisation (CDSCO), headed by the Drugs Controller General of India.⁠[1] Ayushman Bharat PM-JAY gives eligible families hospital cover of up to ₹5 lakh a year.⁠[2]

[1] Central Drugs Standard Control Organisation. Checked 14 Nov 2026.

[2] National Health Authority (PM-JAY). Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for veterinary drugs. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in India.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Veterinary Drugs right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Veterinary Drugs in context

India compared

  • Health spending per person: 85 US$ per person (2023). World: 1,317 US$ per person (2023). 12th highest of the 17 countries we cover in APAC.[1]
  • Doctors: 0.72 per 1,000 people (2020). World: 1.86 per 1,000 people (2022). 13th highest of the 17 countries we cover in APAC.[2]
  • People aged 65 and over: 7.4% of people (2025). World: 10.4% of people (2025). 13th highest of the 18 countries we cover in APAC.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 20 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 20 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 21 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Veterinary Drugs market in India?
Placeholder estimate: about $812.2 Mn in 2025, rising to about $1.92 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Veterinary Drugs market in India growing?
Placeholder estimate: about 10.0% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Veterinary Drugs market report cover?
The report splits the market by product (Anti-Infectives, Anti-Parasitics, Anti-Inflammatories, Vaccines and more) and animal (Dogs, Cats, Cattle, Poultry and more).
Who are the key players in the Veterinary Drugs market?
Key players include Zoetis, Inc, Elanco, Merck & Co., Inc., Boehringer Ingelheim GmbH, Ceva Sante Animale and Virbac.
What is driving the Veterinary Drugs market?
More pet ownership, spending on pet care, rising demand for meat and milk, and concern about animal disease are driving the veterinary drugs market.
Who regulates Veterinary Drugs in India?
New drugs and clinical trials need approval from the Central Drugs Standard Control Organisation (CDSCO), headed by the Drugs Controller General of India. Source: Central Drugs Standard Control Organisation. Checked 14 Nov 2026.
How is healthcare paid for in India?
Ayushman Bharat PM-JAY gives eligible families hospital cover of up to ₹5 lakh a year. Source: National Health Authority (PM-JAY). Checked 14 Nov 2026.
Back to Catalogue

Related Pharmaceuticals reports in India

See all

Related on animal health

See the topic